SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-14-007089
Filing Date
2014-10-03
Accepted
2014-10-03 15:13:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g0914hybio_soligenix.htm SC 13G 22741
  Complete submission text file 0001213900-14-007089.txt   24474
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Subject) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-39976 | Film No.: 141139541
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2500 YORK ROAD SUITE 100 JAMISON PA 18929
Business Address 2500 YORK ROAD SUITE 100 JAMISON PA 18929 215-918-3336
Hy Biopharma Inc (Filed by) CIK: 0001407227 (see all company filings)

IRS No.: 235067192 | Fiscal Year End: 1231
Type: SC 13G